During the past decade, Kenya AIDS Vaccine Initiative conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kenya AIDS Vaccine Initiative" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Fred Hutchinson Cancer Research Center - Seattle HIV Vaccine Trials Unit" with 1 trials as a collaborator, "Kenya AIDS Vaccine Initiative - Institute of Clinical Research (KAVI-ICR)" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kenya AIDS Vaccine Initiative" are "HIV Infections" (3 trials). Many other conditions were trialed in "Kenya AIDS Vaccine Initiative" in a lesser frequency.

Most popular intervention types in "Kenya AIDS Vaccine Initiative" are "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ad35 investigational HIV vaccine" (1 trials), "Ad35-GRIN (0.5mL)" (1 trials), "Adjuvanted GSK investigational HIV vaccine formulation 1" (1 trials), "Adjuvanted GSK investigational HIV vaccine formulation 2" (1 trials) and "BG505 SOSIP.664 gp140, adjuvanted" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kenya AIDS Vaccine Initiative" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kenya AIDS Vaccine Initiative". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kenya AIDS Vaccine Initiative, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kenya AIDS Vaccine Initiative, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".